Suresh Muthukumaraswamy

Suresh Muthukumaraswamy

scientistMale0.0Global Dominance: 0.00%

Dr. Suresh Muthukumaraswamy is a prominent researcher in the field of psychedelic therapy at the University of Auckland School of Pharmacy. He has been instrumental in conducting clinical trials exploring the therapeutic potential of LSD microdosing for mental health issues, particularly depression.

Power0
Reach0
Collect

Not in the pool (under ¢1).

Recent news mentions

Suresh Muthukumaraswamy commented on the positive impact of psilocybin in clinical settings.

Meet the one psychiatrist approved to prescribe magic mushrooms in New Zealand
The New Zealand Herald – country’s largest newspaper, est. 1863·New ZealandNew Zealand· 2025-06-18
6.0
Also mentioned
David Seymour
David Seymour
Lacey
Lacey

Professor Suresh Muthukumaraswamy, from the School of Pharmacy at the University of Auckland, said the changes announced today better aligned New Zealand with Australia.

Sleep drug melatonin to be available over the counter at NZ pharmacies, rules on ‘magic mushrooms’ relaxed
The New Zealand Herald – country’s largest newspaper, est. 1863·New ZealandNew Zealand· 2025-06-18
7.0

Suresh Muthukumaraswamy is leading the University of Auckland study on psychedelics.

Sonia Gray opens up on being in psychedelic drug trials
The New Zealand Herald – country’s largest newspaper, est. 1863·New ZealandNew Zealand· 2025-06-07
6.0
Also mentioned
Sonia Gray
Sonia Gray

Dr Suresh Muthukumaraswamy is leading psychedelic research at the University of Auckland.

Acid test: Why we used Lotto lady as guinea pig in psychedelic therapy trial
The New Zealand Herald – country’s largest newspaper, est. 1863·New ZealandNew Zealand· 2025-06-02
8.0